Boston Scientific Announces Results For Third Quarter 2016

Go back to Boston Scientific Announces Results For Third Quarter 2016

Boston Scientific (BSX) Reports In-Line Q3 EPS; Modestly Lifts Outlook

October 26, 2016 6:33 AM EDT

Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.27, in-line with the analyst estimate of $0.27. Revenue for the quarter came in at $2.11 billion versus the consensus estimate of $2.07 billion.

GUIDANCE:

Boston Scientific sees Q4 2016 EPS of $0.27-$0.29, versus the consensus of $0.27.... More